1. Home
  2. CARG vs NAMS Comparison

CARG vs NAMS Comparison

Compare CARG & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

N/A

Current Price

$28.89

Market Cap

2.6B

Sector

Technology

ML Signal

N/A

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

N/A

Current Price

$21.53

Market Cap

2.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CARG
NAMS
Founded
2005
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
CARG
NAMS
Price
$28.89
$21.53
Analyst Decision
Buy
Strong Buy
Analyst Count
13
16
Target Price
$41.27
★ $49.73
AVG Volume (30 Days)
1.4M
★ 1.7M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 675.00
32.81
EPS
★ 0.87
N/A
Revenue
★ $316,861,000.00
$22,503,000.00
Revenue This Year
$11.86
$30.15
Revenue Next Year
$9.04
$384.12
P/E Ratio
$33.61
★ N/A
Revenue Growth
★ 59.92
N/A
52 Week Low
$26.39
$20.91
52 Week High
$41.22
$42.21

Technical Indicators

Market Signals
Indicator
CARG
NAMS
Relative Strength Index (RSI) 30.32 34.29
Support Level $26.81 $21.02
Resistance Level $36.03 $25.59
Average True Range (ATR) 1.26 1.14
MACD -0.15 -0.02
Stochastic Oscillator 16.58 9.82

Price Performance

Historical Comparison
CARG
NAMS

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: